Home > Journals > SCIREA Journal of Clinical Medicine > Archive > Paper Information

A New Nomogram Model for Individualized Prediction of Cognitive Impairment in Patients With Acute Ischemic Stroke

Volume 6, Issue 6, December 2021    |    PP. 433-447    |PDF (526 K)|    Pub. Date: October 7, 2021
10 Downloads     100 Views  

Anqi Tang, Department of Neurology, The First Affiliated Hospital of Soochow University, No.899 Pinghai Road, Suzhou, Jiangsu 215006, China
Sanjiao Liu, Department of Neurology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, No. 136 Jingzhou Road, Xiangyang, Hubei 441000, China
Zhi Wang, Department of Neurology, The First Affiliated Hospital of Soochow University, No.899 Pinghai Road, Suzhou, Jiangsu 215006, China
Han Shao, Department of Neurology, The First Affiliated Hospital of Soochow University, No.899 Pinghai Road, Suzhou, Jiangsu 215006, China
Xiuying Cai, Department of Neurology, The First Affiliated Hospital of Soochow University, No.899 Pinghai Road, Suzhou, Jiangsu 215006, China
Tan Li, Department of Neurology, The First Affiliated Hospital of Soochow University, No.899 Pinghai Road, Suzhou, Jiangsu 215006, China

Background: Cognitive impairment is common after ischemic stroke, which significantly affects patients’ quality of life and rehabilitation. A reliable scoring tool to detect the risk of cognitive impairment after stroke is imperative. The present study was designed to investigate the risk factors of cognitive impairment in the acute phase and to develop and validate a new nomogram for individualized prediction of cognitive impairment in patients with acute ischemic stroke (AIS).
Methods: We enrolled patients who suffered from AIS and were hospitalized at the First Affiliated Hospital of Soochow University between October 2018 and June 2020. All patients were assessed for cognitive impairment by the Montreal Cognitive Assessment (MoCA) scales within 14 days after the onset of AIS and MoCA score < 26 was defined as having cognitive impairment. The main outcome was the cognitive impairment. All patients were randomly (7:3) divided into two cohorts: the primary cohort and the validated cohort. On the basis of multivariate logistic model, the independent predictors of cognitive impairment in the acute phase were identified and the predictive nomogram was generated. The performance of the nomogram was evaluated by Harrell’s concordance index (C-index) and calibration plot both in the training cohort and validation cohort, respectively.
Results: A total of 191 patients with complete data were enrolled, of whom 135 comprised the primary cohort and 56 comprised the validated cohort. Of pooled analyses, gender, age, baseline NIHSS score, hyperhomocysteinemia (HHcy) and multiple lesions were independently associated with acute cognitive impairment after stroke and included to construct the nomogram. The nomogram derived from the primary cohort had an Area Under Curve (AUC) of 0.764 and the validated cohort had AUC of 0.867. Besides, calibration plot revealed adequate fit of the nomogram in predicting the risk of immediate cognitive impairment in patients with ischemic stroke.
Conclusion: The new nomogram based on gender, age, baseline NIHSS score, HHcy and multiple lesions gave rise to an accurate and comprehensive prediction for cognitive impairment in AIS patients. After further validation, it could be potentially a simple and pragmatic tool for prediction of immediate cognitive impairment of patients suffered from AIS.

Cognitive impairment; Ischemic stroke; Nomogram; Prediction

Cite this paper
Anqi Tang, Sanjiao Liu, Zhi Wang, Han Shao, Xiuying Cai, Tan Li, A New Nomogram Model for Individualized Prediction of Cognitive Impairment in Patients With Acute Ischemic Stroke, SCIREA Journal of Clinical Medicine. Vol. 6 , No. 6 , 2021 , pp. 433 - 447 .


[ 1 ] Kuzma, E., et al., Stroke and dementia risk: A systematic review and meta-analysis. Alzheimers Dement, 2018. 14(11): p. 1416-1426.
[ 2 ] Mellon, L., et al., Cognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study. BMC Neurol, 2015. 15: p. 31.
[ 3 ] Jansen, W.J., et al., Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA, 2015. 313(19): p. 1924-38.
[ 4 ] Saleem, M., et al., Inflammatory Markers in Mild Cognitive Impairment: A Meta-Analysis. J Alzheimers Dis, 2015. 47(3): p. 669-79.
[ 5 ] Pendlebury, S.T. and P.M. Rothwell, Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol, 2009. 8(11): p. 1006-18.
[ 6 ] Brott, T., et al., Measurements of acute cerebral infarction: a clinical examination scale. Stroke, 1989. 20(7): p. 864-70.
[ 7 ] Carson, N., L. Leach, and K.J. Murphy, A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores. Int J Geriatr Psychiatry, 2018. 33(2): p. 379-388.
[ 8 ] Allan, L.M., et al., Long term incidence of dementia, predictors of mortality and pathological diagnosis in older stroke survivors. Brain, 2011. 134(Pt 12): p. 3716-27.
[ 9 ] Kokmen, E., et al., Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology, 1996. 46(1): p. 154-9.
[ 10 ] Brainin, M., et al., Post-stroke cognitive decline: an update and perspectives for clinical research. Eur J Neurol, 2015. 22(2): p. 229-38, e13-6.
[ 11 ] Lee, S., A.C. Shafe, and M.R. Cowie, UK stroke incidence, mortality and cardiovascular risk management 1999-2008: time-trend analysis from the General Practice Research Database. BMJ Open, 2011. 1(2): p. e000269.
[ 12 ] Sun, J.H., L. Tan, and J.T. Yu, Post-stroke cognitive impairment: epidemiology, mechanisms and management. Ann Transl Med, 2014. 2(8): p. 80.
[ 13 ] Katzman, R., et al., A Chinese version of the Mini-Mental State Examination; impact of illiteracy in a Shanghai dementia survey. J Clin Epidemiol, 1988. 41(10): p. 971-8.
[ 14 ] Salvadori, E., et al., Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment. J Neurol, 2013. 260(9): p. 2220-7.
[ 15 ] Surawan, J., et al., Risk factors associated with post-stroke dementia: a systematic review and meta-analysis. Neurol Int, 2017. 9(3): p. 7216.
[ 16 ] He, M., et al., Effects of Blood Pressure in the Early Phase of Ischemic Stroke and Stroke Subtype on Poststroke Cognitive Impairment. Stroke, 2018. 49(7): p. 1610-1617.
[ 17 ] Lim, J.S., et al., Effects of glycemic variability and hyperglycemia in acute ischemic stroke on post-stroke cognitive impairments. J Diabetes Complications, 2018. 32(7): p. 682-687.
[ 18 ] Umarova, R.M., et al., Cognitive reserve impacts on disability and cognitive deficits in acute stroke. J Neurol, 2019. 266(10): p. 2495-2504.
[ 19 ] Takahashi, Y., et al., Visually-Rated Medial Temporal Lobe Atrophy with Lower Educational History as a Quick Indicator of Amnestic Cognitive Impairment after Stroke. J Alzheimers Dis, 2019. 67(2): p. 621-629.
[ 20 ] Akinyemi, R.O., et al., Hippocampal Neurodegenerative Pathology in Post-stroke Dementia Compared to Other Dementias and Aging Controls. Front Neurosci, 2017. 11: p. 717.
[ 21 ] Sperling, R.A., et al., Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement, 2011. 7(3): p. 280-92.
[ 22 ] Jaillard, A., et al., Predicting cognitive dysfunctioning in nondemented patients early after stroke. Cerebrovasc Dis, 2010. 29(5): p. 415-23.
[ 23 ] Weaver, N.A., et al., Strategic infarct locations for post-stroke cognitive impairment: a pooled analysis of individual patient data from 12 acute ischaemic stroke cohorts. Lancet Neurol, 2021. 20(6): p. 448-459.
[ 24 ] Price, B.R., D.M. Wilcock, and E.M. Weekman, Hyperhomocysteinemia as a Risk Factor for Vascular Contributions to Cognitive Impairment and Dementia. Front Aging Neurosci, 2018. 10: p. 350.
[ 25 ] Wu, J.X., et al., Plasma parameters and risk factors of patients with post-stroke cognitive impairment. Ann Palliat Med, 2020. 9(1): p. 45-52.
[ 26 ] Lee, J.H., S.M. Hong, and Y.A. Shin, Effects of exercise training on stroke risk factors, homocysteine concentration, and cognitive function according the APOE genotype in stroke patients. J Exerc Rehabil, 2018. 14(2): p. 267-274.
[ 27 ] Kloppenborg, R.P., et al., Homocysteine and progression of generalized small-vessel disease: the SMART-MR Study. Neurology, 2014. 82(9): p. 777-83.
[ 28 ] Polvikoski, T.M., et al., Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old. Neurology, 2010. 75(23): p. 2071-8.
[ 29 ] Hooshmand, B., et al., Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study. Brain, 2013. 136(Pt 9): p. 2707-16.
[ 30 ] Pavlikova, M., et al., Response of secretory pathways Ca(2+) ATPase gene expression to hyperhomocysteinemia and/or ischemic preconditioning in rat cerebral cortex and hippocampus. Gen Physiol Biophys, 2011. 30 Spec No: p. S61-9.
[ 31 ] Smith, A.D., et al., Homocysteine and Dementia: An International Consensus Statement. J Alzheimers Dis, 2018. 62(2): p. 561-570.
[ 32 ] Kandiah, N., et al., Cognitive Impairment after Mild Stroke: Development and Validation of the SIGNAL2 Risk Score. J Alzheimers Dis, 2016. 49(4): p. 1169-77.
[ 33 ] Ding, M.Y., et al., Predictors of Cognitive Impairment After Stroke: A Prospective Stroke Cohort Study. J Alzheimers Dis, 2019. 71(4): p. 1139-1151.
[ 34 ] Zhao, L., et al., Strategic infarct location for post-stroke cognitive impairment: A multivariate lesion-symptom mapping study. J Cereb Blood Flow Metab, 2018. 38(8): p. 1299-1311.
[ 35 ] Puy, L., et al., Neuroimaging Determinants of Poststroke Cognitive Performance. Stroke, 2018. 49(11): p. 2666-2673.